Spin-Off

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

Amidst industry consolidation, XanEdu spins off to refocus on affordable, custom curriculum, signaling a strategic shift toward specialization in education.

Pictet Asset Management launches two active ETFs for U.S. investors, offering a unique emerging markets strategy that sidesteps China and tech concentration.

With its fiscal 2026 results imminent, STERIS faces high expectations amid market pressures, offering a key indicator for the global healthcare sector.

Freshly spun-off from AnaptysBio, First Tracks Biotherapeutics hits the market with a strong cash position and a pipeline aimed at celiac disease and RA.

The fintech firm spins out from its parent, lowering credit score requirements and promising zero-day closings in a bold move to unlock home equity.

The Canadian retailer celebrates its milestone not just with deals, but with major investments in local charities, reinforcing its unique community-first model.

The masterminds behind BTS's content are launching a new agency, RETOPIA SALON, and their global talent search is coming to Toronto. Here's why.

In a major strategic shift, Old Republic has spun off its TPA division into Lodestar, a new independent brand aiming for growth in a competitive market.

David Bahnsen’s top Forbes ranking coincides with his firm's 11th anniversary, validating a high-growth journey from a Morgan Stanley spin-off to a powerhouse.

A new report reveals a major education gap in obesity care. Informed patients are now demanding options beyond blockbuster drugs like Wegovy and Zepbound.

With its public debut on the horizon, S&P Global Mobility hires a seasoned expert in corporate separations to lead its financial structuring.

Emerging player LunR Royalties finalizes a transformational silver stream on the Fruta Del Norte mine, a move poised to reshape its future and reward Lundin Gold's investors.

After 40 years as a silent partner to global brands, Intercon Chemical is launching its own high-stakes medical cleaning lines to meet new safety standards.

Kanazawa's Hyakumangoku Festival blends samurai legacy with TV fame and a powerful gesture of solidarity for the Noto region's earthquake recovery.

Fancamp Exploration is splitting into two companies, creating a stable royalty firm and a high-stakes gold explorer, Goldera, to unlock shareholder value.

Allspring's closed-end funds offer tempting yields, but tiny shifts in their monthly payouts reveal a complex story of risk, return, and capital erosion.

Lysander Funds plans to convert its Canso Credit Income Fund to an ETF, tapping into a booming active fund market and seeking greater liquidity for investors.

As GLP-1 drug demand soars, Nordic Cold Chain Solutions launches a new lab to solve the complex puzzle of keeping these sensitive medicines safe.

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?